CORTEZ DIAGNOSTICS, INC.

21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367
Tel: (818) 591-3030 Fax: (818) 591-8383
[email protected]
[email protected]
www.rapidtest.com

See external label 2°C-8°C =100 310-100-26

C-REACTIVE PROTEIN

(CRP)
LATEX SLIDE TEST

310-100

INTENDED USE
C- Reactive Protein (CRP) latex slide test is used for the qualitative and semi-quantitative
measurement of C-reactive protein (CRP) in human serum.

INTRODUCTION
C-Reactive Protein (CRP), the classic acute-phase of human serum, is synthesized by hepatocytes.
Normally, it is present only in trace amounts in serum, but it can increase by as much as l000-fold in
response to injury or infection. The clinical measurement of CRP in serum, therefore, appears to be a
valuable screening test for organic disease and a sensitive index of disease activity in inflammatory,
infective, and ischemic conditions. 1,2 MacLeod and Avery found that antibody produced against
purified CRP provided a more sensitive test than the C-polysaccharide assay. 3 Since that time a
number of immunological assays have been devised to measure CRP such as capillary precipitation,
double immunodiffusion, and radical immunodiffusion. 4,5

The CRP reagent kit is based on the principle of the latex agglutination assay described by Singer
and Plotz. 6 The major advantage of this method is the rapid three (3) minute reaction time.

COR Code # 26 1
PRINCIPLE
The CRP reagent kit is based on an immunological reaction between CRP antisera bound to
biologically inert latex particles and CRP in the test specimen. When serum containing greater than
0.8 mgdl CRP is mixed with the latex reagent, visible agglutination occurs.

REAGENTS
1. CRP Latex Reagent: A suspension of uniform polystyrene particles coated with monospecific
antihuman CRP (goat) in glycine buffer, pH 8.8 + 0.5; reagent sensitivity adjusted to
approximately 0.8 mgdl. MIX WELL BEFORE USING.
2. CRP Positive Control Serum: A stabilized prediluted human serum containing more than
0.8 mgdl CRP.
3. CRP Negative Control Serum: A stabilized prediluted human serum non-reactive with the test
reagent.
4. Glycine-Saline Buffer (20x): pH 8.2 ± 0.1: A diluent containing 0.1M glycine and 0.15M NaCl.
Dilute buffer according to instructions on the label before using. All reagents contain 0.1 (wv)
sodium azide as preservative.

WARNINGS AND PRECAUTIONS

1. Reagents containing sodium azide may combine with copper and lead plumbing to form highly
explosive metal azides. Dispose of reagents by flushing with large amounts of water to prevent
azide buildup.
2. For in vitro diagnostic use.
3. Positive and negative controls prepared using human sera found negative for hepatitis B surface
antigen (HBsAg); however, handle controls as if potentially infectious.

REAGENT STORAGE AND STABILITY

1. Reagents are stable until stated expiration date on bottle label when stored refrigerated (2 - 8°C).
2. DO NOT FREEZE.
3. The CRP latex reagent, once shaken must be uniform without visible clumping. When stored
refrigerated, slight sedimentation may occur and should be considered normal.
4. Do not use the latex reagent or controls if they become contaminated.

SPECIMEN COLLECTION AND STORAGE

1. Use fresh serum collected by centrifuging clotted blood.
2. If the test cannot be carried out on the same day, the serum may be stored between 2 - 8°C for
no longer than 72 hours after collection.
3. For longer periods, the sample must be frozen.
4. As in all serological tests, hemolytic or contaminated serum must not be used.
5. Do not use plasma.

MATERIALS AND REAGENTS PROVIDED

1. CRP Latex Reagent
2. CRP Positive Control
3. CRP Negative Control
4. Glycine-Saline Buffer
5. Reaction Slide

COR Code # 26 2
6. PipetteStir Sticks
MATERIALS REQUIRED BUT NOT PROVIDED
1. Timer
2. Test Tubes
3. Test Tube Rack

PROCEDURE
Qualitative Test:
1. Bring reagents and specimens to room temperature before use.
2. Place one drop (50 µl) of the CRP Positive Control on field #1 of the reaction slide. Place one
drop (50 µl) of the CRP Negative Control on field #2. The remaining fields are used for test
specimens. Using pipettes provided, place one drop of the undiluted specimens on successive
fields. Retain pipettestir sticks for mixing step.
3. Gently resuspend the CRP Latex Reagent and add one drop to each test field. Use pipettestir
stick to spread reaction mixture over the entire test field.
4. Rotate the slide for three (3) minutes and read immediately under direct light.

Semi-quantitative Test:
1. Set up at least five test tubes: 1:2, 1:4, 1:8, 1:16, etc.
2. Dilute sample according to dilution factor on each test tube with diluted saline solution.
NOTE: Saline solution has to be diluted with distilled water before use.
3. Place one drop of each of positive and negative controls onto separate slide fields.Place one drop
of each dilution on successive fields of the reaction slides.
4. Gently resuspend the CRP Latex Reagent and add one drop to each test field.
5. Mix well with the flat end of the pipette. Gently rock the slide for three (3) minutes and read
immediately under direct light.
6. The titer of the serum is the reciprocal of the highest dilution exhibiting a positive reaction
multiplied by the concentration of the positive control.

Concentration of reciprocal of last

mg/dL of serum = assay cutoff × dilution showing
control a positive result

Dilution Reciprocal Conc, of serum (mg/dL)

1:2 2 1.6
1:4 4 3.2
1:8 8 6.4

QUALITY CONTROL
1. CRP Positive and Negative Control should be included in each test batch.
2. Acceptable performance is indicated when a uniform milky suspension with no agglutination is
observed with the CRP Negative Control and agglutination with large aggregates is observed with
the CRP Positive Control.

COR Code # 26 3
INTERPRETATION
Negative Result: A negative reaction is indicated by a uniform milky suspension with no
agglutination as observed with the CRP Negative Control.

Positive Result: A positive reaction is indicated by any observable agglutination in the reaction
mixture. The specimen reaction should be compared to the CRP Negative Control (Figure 1).

Positive Negative

Figure 1.

EXPECTED VALUES
1. CRP in healthy individuals is approximately 0.02-1.35mgdl. The mean value in adults is
0.047mgdl.
2. A weak positive correlation was found between CRP and age.
3. It is important to determine the level of CRP for monitoring patient progress. This is due to (1) the
concentration of CRP is an index of tissue damage incurred and (2) increasing or decreasing
levels of CRP (e.g. daily) indicate the progress of inflammatory process. 7

LIMITATIONS
1. Reaction time is critical. If reaction time exceeds three (3) minutes, drying of the reaction mixture
may cause false positive results.
2. Freezing the CRP Latex Reagent will result in spontaneous agglutination.
3. Intensity of agglutination is not necessarily indicative of relative CRP concentration; therefore,
screening reactions should not be graded.
4. A false negative can be attributed to a prozone phenomena (antigen excess). It is recommended,
therefore, to check all negative sera by retesting at a 1:10 dilution with glycine buffer.

PERFORMANCE
1. Sensitivity: greater than 0.8 mgdl
2. Linearity: 25 mg/dl.
3. Comparison:
A. Qualitative Results: A study performed using CRP Latex Reagent and a commercially
available product yielded 100% accuracy.
B. Semi-quantitative Results: A panel of 32 CRP positive serum samples was assayed (semi-
quantitated) on same day. The results of the study indicated that CRP Latex Reagent has
92.9 % precision.

COR Code # 26 4
REFERENCES
1. Pepys, M.B.. Lancet 1:653 (1981).
2. Werner, M.. Clin.Chem. Acta 25:299 (1969).
3. MacLeod, C.M., et. al.. J. Exp. Med 73:191 (1941).
4. Wood, HF., et. al.. J. Clin. Invest. 30: 616 (1951).
5. Mancini, G., et. al.. Immunochemistry 2:235 (1965).
6. Singer, J.M., et. al.. Am. J. Med 21: 888 (1956).
7. Fischer, C.L., Gill,. C.W.. In Serum Protein Abnormalities. Boston, Little, Brown and Co., (1975).

Date Adopted 2016-07-05

310-100 DA-CRP

CORTEZ DIAGNOSTICS, INC.

21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367
Tel: (818) 591-3030 Fax: (818) 591-8383
ISO 13485-2003

Revision Date: 2010-01

COR Code # 26 5